Healthcare Sales & Marketing Network News: aesthetics

Searching News Database: aesthetics

HSMN NewsFeed - 22 May 2026
AbbVie Announces Positive CHMP Opinion for MAVIRET(R) (glecaprevir/pibrentasvir) for the Treatment of Acute Hepatitis C Infection
Biopharmaceuticals Regulatory

HSMN NewsFeed - 1 Oct 2025
Revance Expands Leadership Team with Key Executive Appointments
Devices Dermatology Personnel

HSMN NewsFeed - 14 Feb 2025
AbbVie Appoints CEO Robert A. Michael as Chairman of the Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Feb 2025
AbbVie and Xilio Therapeutics Announce Collaboration and Option Agreement to Develop Novel Tumor-Activated Immunotherapies
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 8 Oct 2024
BTL's Emsculpt Neo Secures FDA Clearance for Treating Medical Diseases and Conditions, Expanding Market Reach
Devices FDA

HSMN NewsFeed - 10 Jul 2024
AbbVie Announces Appointment of Roopal Thakkar, M.D. as Executive Vice President, Research & Development and Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Jun 2024
AbbVie Receives Positive CHMP Opinion for Epcoritamab (TEPKINLY(R)) for the Treatment of Adults with Relapsed/Refractory Follicular Lymphoma
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 21 Feb 2024
AbbVie Announces Appointment of Robert A. Michael as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Feb 2024
AbbVie Completes Acquisition of ImmunoGen
Biopharmaceuticals Oncology Mergers & Acquisitions

HSMN NewsFeed - 20 Oct 2023
Groundbreaking New Silk Surgical Dressing, SYLKE(TM), Launches to Prevent Skin Injuries and Infections, Improving Scarring Outcomes
Devices Surgery Wound Care Product Launch

HSMN NewsFeed - 5 Oct 2023
AbbVie Exercises Exclusive Right to Acquire Mitokinin, Further Strengthening Neuroscience Pipeline
Biopharmaceuticals Neurology Mergers & Acquisitions

HSMN NewsFeed - 14 Sep 2023
Galderma Launches Advanced New Serum with Alastin Skincare(R) - C-Radical Defense Antioxidant Serum
Biopharmaceuticals Dermatology Product Launch

HSMN NewsFeed - 17 Aug 2023
AbbVie Announces European Commission Approval of AQUIPTA(R) (atogepant) for the Preventive Treatment of Migraine in Adults
Biopharmaceuticals Neurology Regulatory

HSMN NewsFeed - 21 Apr 2023
AbbVie Announces Late-Breaking Results from Phase 3 Trial Evaluating Atogepant (QULIPTA(R)) for the Preventive Treatment of Episodic Migraine Among Patients with Prior Treatment Failure at the 2023 AAN Annual Meeting
Biopharmaceuticals Neurology

HSMN NewsFeed - 23 Feb 2023
AbbVie and Capsida Biotherapeutics Expand Strategic Collaboration to Develop Targeted Genetic Medicines for Eye Diseases with High Unmet Need
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 8 Feb 2023
CoolHealth Enters U.S. Market With TargetCool(TM), A Breakthrough FDA-Class II Medical Device Offering Unprecedented Precise, Rapid Cooling For Pain Management And Bruise Minimization
Devices Dermatology Product Launch

HSMN NewsFeed - 6 Feb 2023
Candela Introduces the New FDA-Cleared Profound Matrix(TM) System
Devices Dermatology FDA Product Launch

HSMN NewsFeed - 22 Nov 2022
FDA Clears the Accure Laser System for the Treatment of Mild to Severe Inflammatory Acne Vulgaris
Devices Dermatology FDA

HSMN NewsFeed - 6 Oct 2022
Award-Winning SkinPen(R) Precision Announces New and Expanded Approved Indications
Devices Dermatology FDA

HSMN NewsFeed - 19 Sep 2022
AbbVie Secures Positive CHMP Opinion for Risankizumab (SKYRIZI(R)) for the Treatment of Adults with Moderate to Severe Crohn's Disease
Biopharmaceuticals Gastroenterology Regulatory

HSMN NewsFeed - 20 Jul 2022
AbbVie and iSTAR Medical Announce Strategic Alliance for the Treatment of Glaucoma
Devices Ophthalmology

HSMN NewsFeed - 8 Jul 2022
LASEROPTEK Co. Ltd., and Monarch Lasers Sign a Multi-Year Exclusive Distribution Agreement for the United States Medical Aesthetic Market
Devices Dermatology Distribution

HSMN NewsFeed - 29 Jun 2022
Invictus' Aura Storm Air Purifier Receives FDA 510(k) Class II Medical Device Clearance
Devices FDA

HSMN NewsFeed - 28 Apr 2022
World's First FDA-Approved Cold Ablative Fiber Laser Makes US Debut
Devices Dermatology Product Launch

HSMN NewsFeed - 5 Apr 2022
Allergan, an AbbVie Company, Announces Positive Topline Phase 3 Results Evaluating Investigational Twice-Daily Administration of VUITY(TM) (pilocarpine HCI ophthalmic solution) 1.25% in Adults with Age-Related Blurry Near Vision (Presbyopia)
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 22 Mar 2022
Arthrex Licenses Exclusive Rights from Bimini Health Tech to Globally Commercialize Autopose for Orthopedics and Sports Medicine
Devices Orthopaedic Licensing

HSMN NewsFeed - 8 Feb 2022
FDA Approves JUVÉDERM(R) VOLBELLA(R) XC for Undereye Hollows
Devices Dermatology FDA

HSMN NewsFeed - 7 Feb 2022
Vensica Closes $19 Million Round with Investment from Strategic Partner Merz
Devices Drug Delivery Urology Venture Capital

HSMN NewsFeed - 28 Jan 2022
FDA Accepts Label Update for Plasma IQ(TM), the First FDA-Cleared Handheld Plasma Energy Device
Devices Dermatology FDA

HSMN NewsFeed - 18 Jan 2022
Dermaliq Therapeutics Signs USD 15 Million Series A Round to Advance Three Transformative Drug Therapies into Clinical Trials
Biopharmaceuticals Dermatology Venture Capital

HSMN NewsFeed - 27 Dec 2021
Nobel Biocare Receives FDA 510(k) Clearance for the Nobel Biocare N1(TM) Implant System
Devices Dental FDA

HSMN NewsFeed - 1 Dec 2021
Cutera Launches Next Gen Rapid Muscle Sculpting with truSculpt(R) flex+
Devices Product Launch

HSMN NewsFeed - 16 Nov 2021
Sofwave(TM) Announces FDA clearance of New Lifting Indications for Eyebrow, Sub-Mental (beneath the chin) and Neck Facial Areas
Devices Dermatology FDA

HSMN NewsFeed - 5 Oct 2021
GC Aesthetics(R) Achieves Compelling Surgical And Patient Care Results With FixNip NRI(TM), The Revolutionary Nipple Reconstruction Device
Devices Surgery

HSMN NewsFeed - 13 Sep 2021
AbbVie and REGENXBIO Announce Eye Care Collaboration
Biopharmaceuticals Regenerative Medicine Ophthalmology

HSMN NewsFeed - 24 Aug 2021
European Commission Approves RINVOQ(R) (upadacitinib) as First JAK Inhibitor in the European Union for the Treatment of Both Adults and Adolescents with Moderate to Severe Atopic Dermatitis
Biopharmaceuticals Dermatology Regulatory

HSMN NewsFeed - 9 Aug 2021
SKYRIZI(R) (risankizumab-rzaa) Now Available in the U.S. as a Single 150 mg Injection for Adults with Moderate to Severe Plaque Psoriasis
Biopharmaceuticals Dermatology Product Launch

HSMN NewsFeed - 25 May 2021
GC Aesthetics(R) Launches Next Generation Of Breast Implants
Devices Surgery Product Launch

HSMN NewsFeed - 19 May 2021
SoftWave Tissue Regeneration Technologies Receives FDA Clearance for Blood Circulation Increase, Minor Aches and Pains Relief and Connective Tissue Activation
Devices FDA

HSMN NewsFeed - 10 May 2021
Allergan Aesthetics to Acquire Soliton, Expanding Body Contouring Portfolio
Devices Dermatology Mergers & Acquisitions

HSMN NewsFeed - 8 Apr 2021
Crown Aesthetics Proudly Announces New Indication For Treatment Of Neck Wrinkles For FDA-Cleared Microneedling System, SkinPen(R) Precision
Devices Dermatology FDA

HSMN NewsFeed - 1 Apr 2021
SkinMedica(R) Launches Neck Correct Cream for Neck and Décolleté
Biopharmaceuticals Dermatology Product Launch

HSMN NewsFeed - 8 Mar 2021
Solta Medical Announces the U.S. Launch of The Clear + Brilliant(R) Touch Laser
Devices Dermatology Product Launch

HSMN NewsFeed - 3 Mar 2021
Boston Scientific Announces Agreement To Acquire Lumenis LTD. Surgical Business From Baring Private Equity Asia
Devices Mergers & Acquisitions

HSMN NewsFeed - 10 Feb 2021
AbbVie and Caribou Biosciences Announce Collaboration and License Agreement for CAR-T Cell Products
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 1 Feb 2021
Galderma Receives FDA Approval for Restylane(R) Defyne for Chin Augmentation
Devices Dermatology FDA

HSMN NewsFeed - 28 Jan 2021
Dominion Aesthetic Technologies Closes $23.7 Million Series B Financing to Accelerate the Commercialization of EON
Devices Venture Capital

HSMN NewsFeed - 11 Dec 2020
CHMP Recommends the Approvals of RINVOQ(TM) (Upadacitinib) for the Treatment of Adults with Active Psoriatic Arthritis and Ankylosing Spondylitis
Biopharmaceuticals Regulatory

HSMN NewsFeed - 2 Dec 2020
AbbVie and Frontier Medicines Establish Global Partnership to Discover and Develop Novel Therapies and E3 Degraders Against Difficult-to-Drug Targets
Biopharmaceuticals

HSMN NewsFeed - 4 Nov 2020
Lutronic Introduces Intelligent Care in Muscle Stimulation with IntelliSTIM(TM) - A Third Generation Body Sculpting Device
Devices Product Launch

HSMN NewsFeed - 2 Nov 2020
Soliton Appoints Aesthetic Executive Veteran Brad Hauser as President and Chief Executive Officer in Preparation for Commercial Launch
Devices Dermatology Personnel Product Launch

HSMN NewsFeed - 7 Oct 2020
Allergan Aesthetics, an AbbVie Company, Acquires Innovative Luminera Dermal Filler Business
Devices Dermatology Acquisitions

HSMN NewsFeed - 28 Sep 2020
AbbVie Receives Orphan Drug and Fast Track Designations from the U.S. Food and Drug Administration for Elezanumab, an Investigational Monoclonal Antibody RGMa Inhibitor, for the Treatment of Spinal Cord Injury
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 14 Sep 2020
CollPlant Biotechnologies Signs Distribution Agreement for its Vergenix Flowable Gel Product in the Commonwealth of Independent States (CIS)
Devices Regenerative Medicine Wound Care Distribution

HSMN NewsFeed - 4 Sep 2020
AbbVie and I-Mab Enter into Global Strategic Partnership for Differentiated Immuno-oncology Therapy
Biopharmaceuticals Oncology

HSMN NewsFeed - 27 Aug 2020
Healeon Announces FDA 510(k) Clearance for Duet Office-Based Blood Separation and Concentration System
Devices FDA

HSMN NewsFeed - 10 Jul 2020
Sedana Medical Announces Positive Top Line Result in Pivotal IsoConDa Study
Biopharmaceuticals

HSMN NewsFeed - 22 Jun 2020
FDA Accepts Supplemental Biologics License Application (sBLA) for BOTOX(R) (onabotulinumtoxinA) for the Treatment of Pediatric Patients with Neurogenic Detrusor Overactivity
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 5 May 2020
Galderma Receives FDA Approval For Restylane(R) Kysse, A New Hyaluronic Acid (HA) Filler Specifically Designed And Indicated To Add Fullness To The Lips And Help Smooth The Wrinkles Above The Mouth
Devices Dermatology FDA

HSMN NewsFeed - 1 May 2020
Suneva Medical Increases Its Leadership in Regenerative Aesthetics with New Partnership
Devices Dermatology Distribution

HSMN NewsFeed - 29 Apr 2020
Bimini Health Tech Announces FDA 510(k) Clearance for Dermapose Access Office-Based Fat Harvesting System
Devices Dermatology FDA

HSMN NewsFeed - 23 Apr 2020
R2 Technologies Receives $10M Second Tranche Investment for Landmark CryoAesthetic Technology
Devices Dermatology Venture Capital

HSMN NewsFeed - 22 Apr 2020
Bimini Health Tech Announces FDA 510(k) Clearance for Dermapose Refresh Fat Transfer Technology
Devices Dermatology FDA Product Launch

HSMN NewsFeed - 11 Mar 2020
INVOcell Appoints Yve Lyppens as Director Business Development Asia Pacific
Devices Personnel

HSMN NewsFeed - 9 Mar 2020
BTL Continues to Transform Non-Invasive Aesthetics by Launching the EMSELLA(R) applicator with up to 2.5 Tesla (T) for the EMSCULPT(R) platform(1)
Devices Urology Product Launch

HSMN NewsFeed - 10 Feb 2020
CollPlant Announces Appointment of Roger J. Pomerantz, M.D., F.A.C.P. as Chairman of the Board of Directors
Regenerative Medicine Personnel

HSMN NewsFeed - 30 Jan 2020
Histogen and Allergan Expand Cell Conditioned Media (CCM) Skin Care Partnership
Biopharmaceuticals Regenerative Medicine Licensing

HSMN NewsFeed - 24 Jan 2020
Crown Aesthetics Announces Addition Of ProGen PRP(TM) Advantage To ProGen PRP Portfolio
Devices Dermatology Product Launch

HSMN NewsFeed - 21 Jan 2020
Astanza Laser Wins Marketing/PR Campaign Of The Year, Training Support Of The Year, And Customer Service Of The Year Awards At The 2019 MyFaceMyBody Global Aesthetic Awards
Devices Dermatology

HSMN NewsFeed - 17 Jan 2020
SkinMedica(R) Launches New Instant Bright Eye Cream For Immediate, Visible Results
Biopharmaceuticals Dermatology Product Launch

HSMN NewsFeed - 21 Nov 2019
Silk Medical Aesthetics Completes Enrollment in Clinical Trial for Industry's First Silk-Based Dermal Filler
Devices Dermatology

HSMN NewsFeed - 19 Nov 2019
Baring Private Equity Asia Agrees to Acquire Lumenis
Devices Mergers & Acquisitions

HSMN NewsFeed - 18 Nov 2019
Allergan(R) Announces First Annual National BOTOX(R) Cosmetic (onabotulinumtoxinA) Day
Biopharmaceuticals Dermatology

HSMN NewsFeed - 11 Nov 2019
Allergan Receives FDA Qualified Infectious Disease Product (QIDP) Designation And Fast Track Designation For ATM-AVI (Aztreonam And Avibactam) For Antibiotic-Resistant Gram-Negative Infections
Biopharmaceuticals FDA

HSMN NewsFeed - 28 Oct 2019
Endo Aesthetics Launches New Campaign Elevating Artistry Through Scientific Innovation
Biopharmaceuticals Dermatology

HSMN NewsFeed - 24 Oct 2019
FDA Approves BOTOX(R) (onabotulinumtoxinA) for Pediatric Patients with Lower Limb Spasticity, Excluding Spasticity Caused by Cerebral Palsy
Biopharmaceuticals FDA

HSMN NewsFeed - 21 Oct 2019
SmartPharm Therapeutics Appoints John T. Potts, MD, DSc, to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Sep 2019
CollPlant Biotechnologies Closes on $5.5 Million Financing
Regenerative Medicine Venture Capital

HSMN NewsFeed - 3 Sep 2019
Allergan Receives FDA Approval of Juvéderm VOLUMA(R) XC For Mid-Face Injection Via Cannula
Biopharmaceuticals Devices Dermatology FDA

HSMN NewsFeed - 30 Aug 2019
Allergan Announces Settlement with Two Ohio Plaintiffs in Federal Opioid Litigation
Biopharmaceuticals Litigation

HSMN NewsFeed - 29 Aug 2019
RepliCel Life Sciences Retains Dermatology Sales and Marketing Executive to Guide the Global Commercial Strategy for its Automated Dermal Injector
Regenerative Medicine Dermatology Personnel

HSMN NewsFeed - 5 Aug 2019
CollPlant is Developing 3D-bioprinted Implants for Regeneration of Breast Tissue
Regenerative Medicine

HSMN NewsFeed - 24 Jul 2019
Allergan Voluntarily Recalls BIOCELL(R) Textured Breast Implants and Tissue Expanders
Devices Product Recall

HSMN NewsFeed - 17 Jul 2019
U.S. FDA Accepts Allergan's New Drug Application for Bimatoprost Sustained-Release in Patients with Open-Angle Glaucoma or Ocular Hypertension
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 25 Jun 2019
Dominion Aesthetic Technologies Announces FDA Clearance of eon(TM) FR, Non-Contact Body Sculpting
Devices FDA

HSMN NewsFeed - 25 Jun 2019
AbbVie to Acquire Allergan in Transformative Move for Both Companies
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 24 Jun 2019
Allergan Receives FDA Clearance For CoolTone(TM) Device
Devices Dermatology FDA

HSMN NewsFeed - 21 Jun 2019
FDA Approves BOTOX(R) (onabotulinumtoxinA) for Pediatric Patients with Upper Limb Spasticity
Biopharmaceuticals FDA

HSMN NewsFeed - 20 Jun 2019
CollPlant Announces Corporate Name Change to CollPlant Biotechnologies to Better Reflect Its Business
Regenerative Medicine Wound Care

HSMN NewsFeed - 29 May 2019
LifeSprout, Inc. Closes $6.5 Million Seed Series Financing, Appoints Industry Veteran Adam Gridley as Executive Chairman
Devices Dermatology Venture Capital Personnel

HSMN NewsFeed - 28 Mar 2019
Brian Pilcher, PhD Appointed as Chief Scientific Officer at Suneva Medical
Devices Dermatology Personnel

HSMN NewsFeed - 21 Mar 2019
Soliton Files 510(k) with FDA for its Rapid Acoustic Pulse Device
Devices Dermatology FDA

HSMN NewsFeed - 18 Mar 2019
Allergan Announces FDA Approval of AVYCAZ(R) (ceftazidime and avibactam) for Pediatric Patients
Biopharmaceuticals FDA

HSMN NewsFeed - 11 Mar 2019
Allergan Announces FDA Acceptance of New Drug Application for Ubrogepant for the Acute Treatment of Migraine
Biopharmaceuticals FDA

HSMN NewsFeed - 11 Mar 2019
Study Published in Wounds Journal Shows Remarkable Wound Closure Performance With CollPlant's VergenixFG in the Treatment of Chronic Wounds With a 94% Median Wound Area Reduction Within 4-weeks
Regenerative Medicine Wound Care

HSMN NewsFeed - 8 Mar 2019
Positive Interim Analysis in Pivotal IsoConDa Phase III Study
Biopharmaceuticals Regulatory

HSMN NewsFeed - 7 Mar 2019
FDA Accepts Supplemental Biologics License Applications (sBLAs) for BOTOX(R) (onabotulinumtoxinA) for Pediatric Patients with Upper and Lower Limb Spasticity
Biopharmaceuticals FDA

HSMN NewsFeed - 6 Mar 2019
Patricia Altavilla Appointed as Chief Executive Officer at Suneva Medical
Devices Dermatology Personnel

HSMN NewsFeed - 5 Feb 2019
Lutronic And Syneron-Candela(R) Announce Settlement Of Patent Infringement Lawsuit
Devices Dermatology Litigation

HSMN NewsFeed - 26 Nov 2018
Allergan Makes New Appointments to Finance Leadership Team
Biopharmaceuticals Ophthalmology Dermatology Personnel

HSMN NewsFeed - 5 Nov 2018
Galderma Announces FDA Approval of Restylane(R) Lyft For Midface Injection via Cannula
Devices Dermatology FDA

HSMN NewsFeed - 16 Oct 2018
FDA Approves Medicines360's sNDA for LILETTA(R) (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Five Years
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 9 Oct 2018
Mike McDonald Joins Synergy MedSales as Chief Financial Officer
Devices Dermatology Personnel Distribution

HSMN NewsFeed - 4 Oct 2018
Allergan Receives FDA Clearance To Treat Area Below The Jawline With CoolSculpting(R)
Devices Dermatology FDA

HSMN NewsFeed - 17 Sep 2018
U.S. FDA Clears Sebacia Microparticles for the Treatment of Mild to Moderate Inflammatory Acne
Devices Dermatology FDA

HSMN NewsFeed - 14 Sep 2018
Allergan to Acquire Bonti Adding New Neurotoxin Programs to Medical Aesthetics Pipeline
Biopharmaceuticals Dermatology Mergers & Acquisitions

HSMN NewsFeed - 8 Aug 2018
Allergan Appoints Neurobiology Expert Michael E. Greenberg, PhD to its Board of Directors as Part of Active Board Refreshment Process
Biopharmaceuticals Ophthalmology Dermatology Personnel

HSMN NewsFeed - 23 Jul 2018
Allergan Receives FDA Fast Track Designation for AGN-241751 for the Treatment of Major Depressive Disorder (MDD)
Biopharmaceuticals FDA

HSMN NewsFeed - 14 Jun 2018
Allergan Continues Active Board Refreshment Process
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Jun 2018
Cytrellis Biosystems Completes $28.5 Million Series B Financing
Devices Dermatology Venture Capital Personnel

HSMN NewsFeed - 24 Apr 2018
Urovant Sciences Strengthens Executive Management Team with Senior Hires and Establishes U.S. Headquarters in Irvine, California
Biopharmaceuticals Urology Personnel

HSMN NewsFeed - 12 Apr 2018
CollPlant Appoints Revital Mandil-Levin as Chief Business Development Officer
Regenerative Medicine Personnel

HSMN NewsFeed - 23 Mar 2018
Amgen And Allergan Receive Positive CHMP Opinion For ABP 980 (Biosimilar Herceptin(R)) For The Treatment Of Three Types Of Cancer
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 14 Feb 2018
Plastic And Reconstructive Surgery Journal Publishes Ten-Year Clinical Study Data Highlighting Safety Of MENTOR(R) MemoryShape(R) Gel Breast Implants
Devices Surgery

HSMN NewsFeed - 2 Feb 2018
FDA Approves AVYCAZ(R) (ceftazidime and avibactam) for the Treatment of Patients with Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia
Biopharmaceuticals FDA

HSMN NewsFeed - 18 Dec 2017
Allergan Announces Promotion of Wayne Swanton to Executive Vice President, Global Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Dec 2017
Allergan Receives FDA Clearance For the CoolSculpting(R) Treatment To Improve Appearance Of Lax Tissue In The Double Chin
Devices Dermatology FDA

HSMN NewsFeed - 13 Nov 2017
Allergan Receives FDA Approval For Use of VRAYLAR(TM) (cariprazine) in the Maintenance Treatment of Schizophrenia
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 10 Oct 2017
Allergan Announces that the FDA Accepts New Drug Application for Ulipristal Acetate for Uterine Fibroids
Biopharmaceuticals FDA

HSMN NewsFeed - 6 Oct 2017
Sientra Supports Reconstructive Breast Patients with Launch of Full Circle(TM) Grant Program and Revolutionary Portfolio of Tissue Expanders
Devices Oncology Product Launch

HSMN NewsFeed - 4 Oct 2017
New Breast Implant For Patients Undergoing Breast Reconstruction, Augmentation Or Revision Surgery
Devices Product Launch

HSMN NewsFeed - 4 Oct 2017
Solta Medical Receives FDA 510(k) Clearance for Thermage FLX(TM) System, Newest Generation Skin Smoothing Technology
Devices Dermatology FDA

HSMN NewsFeed - 25 Sep 2017
Allergan Announces Tessa Hilado, Executive Vice President and Chief Financial Officer, to Retire from Company
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Sep 2017
Recros Medica Appoints Thomas A. Albright as President and CEO
Devices Dermatology Personnel

HSMN NewsFeed - 7 Aug 2017
FDA Approves Medicines360's sNDA for LILETTA(R) (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Four Years
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 31 Jul 2017
Amgen and Allergan Submit Biosimilar Biologics License Application for ABP 980 to US Food and Drug Administration
Biopharmaceuticals Generics Oncology FDA

HSMN NewsFeed - 25 Jul 2017
Early Treatment Is Revolutionizing Outcome Of Burn Scars
Devices Dermatology

HSMN NewsFeed - 6 Jul 2017
PhotonMD Appoints Robert Catlin as Senior Director of Marketing
Devices Personnel

HSMN NewsFeed - 15 Jun 2017
Hologic Receives Expanded FDA 510(k) Clearance to Market Cynosure's SculpSure(R) for Non-Invasive Body Contouring (Lipolysis) of Back, Inner and Outer Thighs
Devices FDA

HSMN NewsFeed - 28 Apr 2017
Allergan Successfully Completes ZELTIQ(R) Aesthetics Acquisition
Devices Mergers & Acquisitions

HSMN NewsFeed - 28 Apr 2017
MENTOR(R) Launches MENTORPromise Protection Plan
Devices Product Launch

HSMN NewsFeed - 27 Apr 2017
Allergan Announces Advisory Role for Breast Implant Pioneer Hani Zeini
Biopharmaceuticals Devices Personnel

HSMN NewsFeed - 24 Apr 2017
Millennium Medical Technologies (MMT) First in the Nation to Receive FDA Clearance for a Reusable Fat Collection and Grafting System
Devices Surgery FDA

HSMN NewsFeed - 18 Apr 2017
Allergan Expands Leading Research & Development NASH Program with Novartis Clinical Collaboration
Biopharmaceuticals

HSMN NewsFeed - 24 Mar 2017
Richard Peterson Joins Sienna Biopharmaceuticals As Chief Financial Officer
Biopharmaceuticals Dermatology Personnel

HSMN NewsFeed - 22 Mar 2017
Allergan Announces Availability of RESTASIS MULTIDOSE(TM) (Cyclosporine Ophthalmic Emulsion) 0.05% -- the First FDA-Approved Preservative Free Prescription Eye Drop Available in a Multidose Bottle
Biopharmaceuticals Ophthalmology Product Launch

HSMN NewsFeed - 20 Mar 2017
JUVÉDERM VOLLURE(TM) XC Approved by U.S. FDA for Correction of Facial Wrinkles and Folds in Adults over the Age of 21
Devices Dermatology FDA

HSMN NewsFeed - 1 Feb 2017
Sanofi Appoints Hugo Fry as General Manager UK
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Feb 2017
Syneron Medical Strengthens Senior Management Team with Appointment of Chief Human Resources Officer
Devices Dermatology Personnel

HSMN NewsFeed - 17 Jan 2017
Allergan and Gedeon Richter Announce Positive Phase III Results for Ulipristal Acetate 5 and 10 mg in the Treatment of Uterine Fibroids
Biopharmaceuticals

HSMN NewsFeed - 10 Jan 2017
ZELTIQ Aesthetics, Inc. Announces Commercial Leadership Transition
Devices Dermatology Personnel

HSMN NewsFeed - 13 Dec 2016
Valeant Appoints William D. Humphries As EVP, Dermatology
Biopharmaceuticals Dermatology Personnel

HSMN NewsFeed - 2 Dec 2016
Allergan Announces Settlement of a DELZICOL(R) (mesalamine) Patent Litigation
Biopharmaceuticals Litigation

HSMN NewsFeed - 29 Nov 2016
Cynosure Receives CFDA Clearance to Market the Icon(TM) Aesthetic System in China
Devices Dermatology Regulatory

HSMN NewsFeed - 23 Nov 2016
Allergan Acquires Chase Pharmaceuticals to Expand CNS R&D Pipeline and Build on Commitment to Alzheimer's Disease
Biopharmaceuticals Neurology Mergers & Acquisitions

HSMN NewsFeed - 22 Nov 2016
Allergan Receives FDA Clearance for the XEN(R) Gel Stent, a New Surgical Treatment for Refractory Glaucoma
Devices Ophthalmology FDA

HSMN NewsFeed - 16 Nov 2016
Quanta Aesthetic Lasers Promotes Michael Sparks to Chief Executive Officer
Devices Dermatology Personnel

HSMN NewsFeed - 11 Nov 2016
Sofregen Medical Acquires SERI(R) Surgical Scaffold Product Line from Allergan
Devices Surgery Acquisitions

HSMN NewsFeed - 10 Nov 2016
Allergan Announces Launch of TAYTULLA(TM) (Norethindrone Acetate and Ethinyl Estradiol Capsules and Ferrous Fumarate Capsules) 1 mg/20 mcg, the First and Only Oral Contraceptive Softgel Capsule
Biopharmaceuticals Product Launch

HSMN NewsFeed - 28 Oct 2016
Allergan Introduces RESTASIS MULTIDOSE(TM) (Cyclosporine Ophthalmic Emulsion) 0.05%, a New Delivery System for the One and Only FDA Approved Treatment to Help Patients Produce More of Their Own Tears
Biopharmaceuticals Ophthalmology FDA Product Launch

HSMN NewsFeed - 25 Oct 2016
Allergan Successfully Completes Vitae Tender Offer
Biopharmaceuticals Dermatology Mergers & Acquisitions

HSMN NewsFeed - 17 Oct 2016
Allergan and Vitae Pharmaceuticals Announce Expiration of HSR Waiting Period for Allergan's Proposed Acquisition of Vitae
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 3 Oct 2016
Allergan plc Enters Into Licensing Agreement with AstraZeneca to Obtain Worldwide Rights to MEDI2070 Inflammatory Disorder Development Program
Biopharmaceuticals Gastroenterology Licensing

HSMN NewsFeed - 29 Sep 2016
Allergan Issues Statement on Namenda XR Patent Litigation Following Announcement of ANDA Approvals
Biopharmaceuticals Generics FDA Litigation

HSMN NewsFeed - 29 Sep 2016
Avita Medical Signs Exclusive Distributor Deal in Iran
Devices Regenerative Medicine Distribution

HSMN NewsFeed - 20 Sep 2016
Allergan to Acquire Tobira Therapeutics Expanding Global GI R&D Pipeline and Taking a Leading R&D Position in NASH
Biopharmaceuticals Gastroenterology Mergers & Acquisitions

HSMN NewsFeed - 31 Aug 2016
Allergan and Adamas Announce Settlement with Amneal Related to NAMZARIC(R) Patent Litigation
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 30 Aug 2016
Oculus Innovative Sciences Launches Lasercyn(TM) into U.S. Dermatology Market for Use Following Laser Procedures, Microdermabrasions and Chemical Peels
Biopharmaceuticals Dermatology Product Launch

HSMN NewsFeed - 3 Aug 2016
Allergan Announces Sale of Anda Distribution Business to Teva Pharmaceutical
Biopharmaceuticals Distribution Acquisitions

HSMN NewsFeed - 23 Jun 2016
Allergan Announces FDA Approval of Supplemental New Drug Application (sNDA) for AVYCAZ(R) (ceftazidime and avibactam)
Biopharmaceuticals FDA

HSMN NewsFeed - 14 Jun 2016
Suneva Medical Closes $25 Million Financing To Support Continued Growth Opportunities
Devices Dermatology Venture Capital

HSMN NewsFeed - 6 Jun 2016
Allergan Announces FDA Approval of BYVALSON(TM) (nebivolol and valsartan)
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 31 May 2016
Allergan Receives FDA Approval of TEFLARO(R) (ceftaroline fosamil) for Pediatric Patients
Biopharmaceuticals FDA

HSMN NewsFeed - 24 May 2016
Allergan Announces FDA Acceptance of NDA Filing for Oxymetazoline HCI Cream 1.0%
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 16 May 2016
Allergan Announces Positive Pivotal Trial Results for Oculeve Intranasal Tear Neurostimulator
Devices Ophthalmology

HSMN NewsFeed - 9 May 2016
Allergan and Richter Announce Positive Phase III Results for Ulipristal Acetate 5 and 10 mg in the Treatment of Uterine Fibroids
Biopharmaceuticals

HSMN NewsFeed - 2 May 2016
Allergan Receives FDA Approval and Launches First Generic Version of CRESTOR(R) (rosuvastatin)
Biopharmaceuticals Generics FDA Product Launch

HSMN NewsFeed - 29 Apr 2016
Allergan Receives CHMP Positive Opinion For ENZEPI(R) (Pancrelipase) For Patients With Exocrine Pancreatic Insufficiency (EPI)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 20 Apr 2016
Oculus Innovative Sciences Receives U.S. FDA Approval for Lasercyn(TM) for Use Following Laser Procedures, Microdermabrasions and Chemical Peels
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 6 Apr 2016
Allergan Reiterates Strong Standalone Growth Profile and Strategy Following Termination of Pfizer Transaction
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 23 Mar 2016
Perrigo And Allergan Announce First-To-Market Launch Of Store Brand OTC Equivalent To Mucinex(R) 1200mg ER Tablets
Biopharmaceuticals Product Launch

HSMN NewsFeed - 17 Mar 2016
Allergan Confirms Generic Abraxane(R) Patent Challenge
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 16 Mar 2016
Ember Therapeutics Enhances Regenerative Medicine Pipeline With Acquisition of ICX-RHY/Vavelta(TM) from Intercytex
Regenerative Medicine Dermatology Acquisitions

HSMN NewsFeed - 16 Mar 2016
Allergan Announces U.S. Availability of VRAYLAR(TM) (cariprazine) for Treatment of Bipolar Mania and Schizophrenia in Adults
Biopharmaceuticals Product Launch

HSMN NewsFeed - 10 Mar 2016
Allergan Receives Complete Response Letter from FDA for Prior Approval Supplement for RESTASIS(R) (Cyclosporine Ophthalmic Emulsion) 0.05% Multi-Dose Preservative-Free Bottle
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 3 Mar 2016
Allergan Launches Bold Access To LILETTA(R) (levonorgestrel-releasing intrauterine system)
Biopharmaceuticals Drug Delivery Product Launch

HSMN NewsFeed - 2 Mar 2016
Envy Medical, Inc. Appoints Arash A. Khazei As Chief Executive Officer
Devices Dermatology Personnel

HSMN NewsFeed - 29 Feb 2016
Allergan Announces Receipt Of FDA Acceptable For Filing Letter For Generic XIFAXAN(R) ANDA
Biopharmaceuticals Generics Gastroenterology FDA

HSMN NewsFeed - 24 Feb 2016
FDA Accepts and Grants Priority Review for AVYCAZ(R) (ceftazidime and avibactam) Supplemental New Drug Application (sNDA)
Biopharmaceuticals FDA

HSMN NewsFeed - 16 Feb 2016
FDA Accepts Supplemental New Drug Application (sNDA) for TEFLARO(R) (ceftaroline fosamil)
Biopharmaceuticals FDA

HSMN NewsFeed - 29 Jan 2016
Allergan Announces Collaboration with AstraZeneca to Develop and Commercialize ATM-AVI (aztreonam and avibactam) for Antibiotic-Resistant Gram-Negative Infections
Biopharmaceuticals Licensing Distribution

HSMN NewsFeed - 29 Jan 2016
Allergan's Rapastinel Receives FDA Breakthrough Therapy Designation for Adjunctive Treatment of Major Depressive Disorder (MDD)
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 22 Jan 2016
U.S. FDA Approves BOTOX(R) (onabotulinumtoxinA) for the Treatment of Lower Limb Spasticity in Adults
Biopharmaceuticals FDA

HSMN NewsFeed - 21 Jan 2016
Allergan Announces FDA Approval of Updated Label for New Dosing Regimen for DALVANCE(R) (dalbavancin)
Biopharmaceuticals FDA

HSMN NewsFeed - 21 Jan 2016
VIBERZI(TM) (eluxadoline) Phase III Trial Results Published in The New England Journal of Medicine
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 14 Jan 2016
Avita Medical Appoints Distributors in Japan and South Korea
Devices Wound Care Distribution

HSMN NewsFeed - 12 Jan 2016
ZELTIQ Announces Executive Leadership Addition and Global Commercial Operations Realignment
Devices Dermatology Personnel

HSMN NewsFeed - 14 Dec 2015
Allergan Announces U.S. Availability of VIBERZI(TM) (eluxadoline) for Treatment of Irritable Bowel Syndrome with Diarrhea (IBS-D) in Adults
Biopharmaceuticals Gastroenterology Product Launch

HSMN NewsFeed - 23 Nov 2015
Pfizer and Allergan to Combine
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 4 Nov 2015
Allergan Enters Into Licensing Agreement with Mimetogen Pharmaceuticals to Develop and Commercialize Tavilermide (MIM-D3) Topical Dry Eye Treatment
Biopharmaceuticals Ophthalmology Licensing

HSMN NewsFeed - 4 Nov 2015
Allergan to Acquire earFold(TM), an Innovative Medical Device for the Correction of Prominent Ears
Devices Acquisitions

HSMN NewsFeed - 29 Oct 2015
Allergan plc Confirms Discussions Regarding Potential Business Combination Transaction With Pfizer Inc.
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 27 Oct 2015
Allergan Acquires Rights To Ironwood's CONSTELLA(R) (Linaclotide) From Almirall In More Than 40 Countries
Biopharmaceuticals Gastroenterology Acquisitions

HSMN NewsFeed - 1 Oct 2015
U.S. FDA Approves JUVEDERM(R) ULTRA XC for Use in Lips
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 7 Jul 2015
Allergan Enters Into Licensing Agreement with Merck to Obtain Exclusive Worldwide Rights to CGRP Migraine Development Program
Biopharmaceuticals Acquisitions Licensing

HSMN NewsFeed - 6 Jul 2015
Allergan to Acquire Oculeve Dry Eye Disease Development Programs
Biopharmaceuticals Ophthalmology Mergers & Acquisitions

HSMN NewsFeed - 2 Jul 2015
Galderma Receives FDA Approval to Market Restylane(R) Lyft with Lidocaine to Correct Age Related Volume Loss in the Cheek Area
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 17 Jun 2015
Allergan to Acquire KYTHERA Biopharmaceuticals
Biopharmaceuticals Dermatology Mergers & Acquisitions

HSMN NewsFeed - 9 Jun 2015
Luqa Pharmaceuticals Completes US$15M Series A Financing
Biopharmaceuticals Dermatology Venture Capital

HSMN NewsFeed - 18 May 2015
Actavis Launches NAMZARIC(TM) (memantine hydrochloride extended-release and donepezil hydrochloride), a Fixed-Dose Combination Therapy for the Treatment of Moderate to Severe Alzheimer's Disease
Biopharmaceuticals Neurology Product Launch

HSMN NewsFeed - 13 Apr 2015
Actavis and Medicines360 Announce U.S. Availability of LILETTA(TM) (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Three Years
Biopharmaceuticals Product Launch

HSMN NewsFeed - 27 Feb 2015
FDA Approves Allergan’s NATRELLE INSPIRA(TM) Round Gel-Filled Breast Implants
Devices FDA

HSMN NewsFeed - 10 Nov 2014
BSD Medical Names Medical Device Veteran Clint Carnell President and Chief Executive Officer
Devices Oncology Personnel

HSMN NewsFeed - 29 Sep 2014
Allergan Announces FDA Approves Revised Indication for OZURDEX(R) (dexamethasone intravitreal implant) 0.7 mg for the Treatment of Diabetic Macular Edema
Biopharmaceuticals Ophthalmology Drug Delivery FDA

HSMN NewsFeed - 29 Sep 2014
Allergan Board of Directors Issues Statement
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 12 Aug 2014
Lithera Announces Company Name Change to Neothetics, Inc.
Biopharmaceuticals Dermatology

HSMN NewsFeed - 30 Jun 2014
Allergan Announces R&D Pipeline Update and U.S. FDA Approval; Company to Host Conference Call Today, Monday, June 30th at 10:30 AM ET
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 28 May 2014
Allergan Confirms Receipt of Revised, Unsolicited Proposal from Valeant
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 12 May 2014
Allergan Board Unanimously Rejects Unsolicited Proposal from Valeant
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 1 May 2014
BOTOX(R) (Botulinum Toxin Type A) Receives a Positive Opinion in Fourteen European Countries for the Treatment of Focal Spasticity of the Ankle in Adult Post Stroke Patients
Biopharmaceuticals Regulatory

HSMN NewsFeed - 14 Apr 2014
ZELTIQ Announces FDA Clearance to Treat Thighs
Devices Dermatology FDA

HSMN NewsFeed - 21 Mar 2014
ZELTIQ(R) Aesthetics Launches CoolSmooth(TM) Applicator
Devices Dermatology Product Launch

HSMN NewsFeed - 5 Mar 2014
Revance to Add Angus C. Russell as Chairman to Its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Feb 2014
GC Aesthetics raises $60M to Fund Global Growth and New Product Development
Devices Dermatology Venture Capital

HSMN NewsFeed - 20 Feb 2014
Syneron Medical Acquires New Star Lasers
Devices Dermatology Mergers & Acquisitions

HSMN NewsFeed - 12 Feb 2014
DEKA Medical Receives FDA Clearance for the Synchro REPLA:Y
Devices Dermatology FDA

HSMN NewsFeed - 4 Feb 2014
BOTOX(R) (Botulinum toxin type A) Receives Approval in the UK for the Treatment of Ankle Disability due to Lower Limb Spasticity Associated with Stroke in Adults
Biopharmaceuticals Neurology Regulatory

HSMN NewsFeed - 30 Jan 2014
Ulthera(R) System Receives Third FDA Clearance
Devices Dermatology FDA

HSMN NewsFeed - 9 Jan 2014
Covidien, Lightstone Ventures, New Enterprise Associates Announce Series A Investment in FIRE1
Devices Venture Capital Personnel

HSMN NewsFeed - 7 Jan 2014
Allergan, Inc. and Medytox, Inc. Complete Licensing Agreement
Biopharmaceuticals Licensing

HSMN NewsFeed - 2 Jan 2014
NeXeption, LLC Forms New Company Alexar Therapeutics, Inc. to Develop Novel LXR Agonist Portfolio for Dermatologic Indications; Raises $21.5 Million in Series A Financing
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 16 Dec 2013
Valeant Pharmaceuticals Agrees to Acquire Solta Medical for $2.92 Per Share in Cash
Biopharmaceuticals Devices Mergers & Acquisitions

HSMN NewsFeed - 21 Nov 2013
Lithera Announces Appointment of Dermatology and Aesthetics Authority Dr. Lincoln Krochmal as Chief Medical Officer
Biopharmaceuticals Dermatology Personnel

HSMN NewsFeed - 18 Nov 2013
Solta Medical Secures $40 Million Financing
Devices Dermatology Venture Capital

HSMN NewsFeed - 23 Oct 2013
FDA Approves JUVÉDERM VOLUMA(TM) XC
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 2 Oct 2013
KLOX Technologies Announces Approval in Canada of its Innovative Acne Vulgaris Treatment
Devices Dermatology Regulatory

HSMN NewsFeed - 5 Aug 2013
Merz North America Announces the Appointment of John Donofrio as Chief Financial Officer and Head of North American Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Jul 2013
Mentor Announces Collaboration Agreement With Valeant Pharmaceuticals
Devices Distribution

HSMN NewsFeed - 20 Jun 2013
Fraxel(R) Dual Laser System Receives New FDA 510(k) Clearance For Treatment Of Skin Pigmentation
Devices Dermatology FDA

HSMN NewsFeed - 12 Jun 2013
Mark Sieczkarek Elected Chairman of the Board of Solta Medical
Devices Dermatology Personnel

HSMN NewsFeed - 12 Jun 2013
Mentor Announces Launch of CPX(TM)4 Tissue Expander in EMEA
Devices Product Launch

HSMN NewsFeed - 14 May 2013
Suneva Medical Announces Results of Its Pivotal ArteFill(R) Acne Scar Study
Devices Dermatology

HSMN NewsFeed - 6 May 2013
Solta Medical Announces The Thermage(R) Total Tip
Devices Dermatology

HSMN NewsFeed - 29 Apr 2013
Integra LifeSciences Launches Integra(R) Compact Cranial Closure System
Devices Neurosurgery Product Launch

HSMN NewsFeed - 20 Mar 2013
Valeant Pharmaceuticals International, Inc. Agrees to Acquire Obagi Medical Products, Inc. for $19.75 Per Share in Cash
Biopharmaceuticals Dermatology Mergers & Acquisitions

HSMN NewsFeed - 27 Feb 2013
Bill Brodie Joins myoscience as Vice President of Global Sales and Marketing
Devices Personnel

HSMN NewsFeed - 26 Feb 2013
Brickell Biotech Announces $7M Series B Financing to Fund Development of Novel Dermatology Treatments
Biopharmaceuticals Dermatology Venture Capital

HSMN NewsFeed - 21 Feb 2013
FDA Approves Natrelle(R) 410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast Implants
Devices FDA

HSMN NewsFeed - 19 Feb 2013
Dune Medical Devices Announces European Union Approval of the MarginProbe(R) System Type 1.2
Devices Oncology Regulatory

HSMN NewsFeed - 30 Jan 2013
Mercantile Court in Spain Rules in ZELTIQ(R) Aesthetics Patent Infringement Lawsuit Against Clinipro
Devices Litigation

HSMN NewsFeed - 25 Jan 2013
The Cooper Companies Board Appoints New Director
Devices Ophthalmology Personnel

HSMN NewsFeed - 23 Jan 2013
Allergan, Inc. to Acquire MAP Pharmaceuticals, Inc.
Biopharmaceuticals Neurology Mergers & Acquisitions

HSMN NewsFeed - 17 Dec 2012
Andrew Technologies Receives FDA 510(k) Clearance for Commercial Version of HydraSolve(TM) Lipoplasty System
Devices Surgery FDA

HSMN NewsFeed - 28 Nov 2012
Valeant Pharmaceuticals Announces New Management Appointments
Biopharmaceuticals Dermatology Personnel

HSMN NewsFeed - 16 Nov 2012
Allergan, Inc. to Acquire SkinMedica, Inc.
Biopharmaceuticals Dermatology Mergers & Acquisitions

HSMN NewsFeed - 22 Oct 2012
Nuvo and Galderma Announce FDA Approval of Pliaglis(R)
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 24 Sep 2012
FzioMed Announces 300,000 Units of Oxiplex Sold
Devices Orthopaedic Neurosurgery

HSMN NewsFeed - 17 Sep 2012
Merz, Inc. Announces Cynthia Schwalm as Vice President, Neurology
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 10 Sep 2012
ZELTIQ(R) Aesthetics Announces Resignation of President of Its North American Franchise
Devices Dermatology Personnel

HSMN NewsFeed - 27 Aug 2012
ZELTIQ(R) Aesthetics Intellectual Property and Patents Validated in Settlement against SkinSpaMed
Devices Litigation

HSMN NewsFeed - 24 Aug 2012
ZELTIQ(R) Aesthetics Appoints Mark J. Foley as President and Chief Executive Officer
Devices Personnel

HSMN NewsFeed - 14 Aug 2012
Pharmacyclics(R) Appoints Joshua T. Brumm Executive Vice President of Finance
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Jun 2012
ZELTIQ(R) Aesthetics Promotes Robert Tyson to Vice President of North America Sales
Devices Dermatology Personnel

HSMN NewsFeed - 31 May 2012
Solta Medical Announces Latest Advance in Fraxel(R) Laser Technology
Devices Dermatology

HSMN NewsFeed - 8 May 2012
ZELTIQ(R) Aesthetics Promotes Joshua T. Brumm to Senior Vice President
Devices Personnel

HSMN NewsFeed - 4 May 2012
New HydraSolve(TM) Lipoplasty System launched at American Society of Aesthetic Plastic Surgery Meeting
Devices Surgery

HSMN NewsFeed - 13 Apr 2012
BOTOX(R) Cosmetic (onabotulinumtoxinA) Celebrates 10-Year Anniversary of U.S. Food and Drug Administration Approval
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 2 Apr 2012
Solta Medical Introduces Liposonix(R) at AMWC in Monaco and Announces its Portfolio of Aesthetic Energy Devices Reaches Industry Milestone With More Than 2 Million Procedures Completed Globally
Devices

HSMN NewsFeed - 19 Mar 2012
ZELTIQ Aesthetics, Inc. Names Mike Genau President of Its North American Franchise
Devices Personnel

HSMN NewsFeed - 14 Mar 2012
The Merz Pharma Group Appoints William D. Humphries As New North American Chief Executive Officer
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 14 Mar 2012
KYTHERA Biopharmaceuticals Appoints Industry Veteran Elisabeth Sandoval as Chief Commercial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Feb 2012
Syneron Announces New Ground Breaking evolastin(TM) Procedure
Devices Dermatology

HSMN NewsFeed - 25 Jan 2012
ZELTIQ(R) Initiates Patent Infringement Lawsuit Against Clinipro
Devices Litigation

HSMN NewsFeed - 23 Jan 2012
FzioMed Receives CE Mark for DYNAVISC(R) Gel
Devices Surgery Regulatory

HSMN NewsFeed - 3 Jan 2012
Cutera and IRIDEX Announce Acquisition of IRIDEX' Aesthetic Business Unit
Devices Dermatology Acquisitions

HSMN NewsFeed - 23 Dec 2011
Allergan Reassures Patients and Surgeons of the Quality and Safety of Its Breast Implant Devices Sold and Distributed Worldwide
Devices

HSMN NewsFeed - 21 Jul 2011
Merz Aesthetics Announces FDA Approval Of XEOMIN(R) (incobotulinumtoxinA) For The Temporary Improvement In The Appearance Of Moderate To Severe Glabellar Lines In Adult Patients
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 19 Jul 2011
Allergan, Inc. to Acquire Privately Held Dermatologic Company, Vicept Therapeutics
Biopharmaceuticals Dermatology Mergers & Acquisitions

HSMN NewsFeed - 6 May 2011
Solta Medical Announces FDA 510(k) Clearance for New Clear + Brilliant Technology
Devices Dermatology FDA

HSMN NewsFeed - 18 Mar 2011
Solta Medical Transitions Leadership Team
Devices Personnel

HSMN NewsFeed - 8 Feb 2011
Ulthera Announces $10.5 Million in Series C Venture Capital Funding
Devices Venture Capital

HSMN NewsFeed - 11 Nov 2010
PDS(TM) Flexible Plate, a Unique Absorbable Implant, for Nasal Reconstruction, Now Available in the U.S.
Devices Surgery

HSMN NewsFeed - 8 Nov 2010
Aqua Pharmaceuticals Welcomes David Crean as Vice President, Corporate Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Oct 2010
Nicholas L. Teti, Jr. Appointed President and CEO of Suneva Medical
Devices Personnel

HSMN NewsFeed - 11 Oct 2010
Discus Dental Acquired by Philips
Devices Dental Mergers & Acquisitions

HSMN NewsFeed - 11 Oct 2010
Alphatec Holdings Announces Appointment of Michael O'Neill, FCMA, as Chief Financial Officer
Devices Orthopaedic Neurosurgery Personnel

HSMN NewsFeed - 11 Oct 2010
GC Aesthetics Secures $30 Million in Financing from Montreux Equity Partners
Devices Venture Capital

HSMN NewsFeed - 31 Aug 2010
Allergan, Inc. Receives FDA Approval for LUMIGAN(R) 0.01% as First-Line Therapy Indicated for the Reduction of Elevated Intraocular Pressure in Glaucoma Patients
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 9 Jul 2010
BOTOX(R) Receives First Authorisation in UK as Preventative Treatment in Chronic Migraine
Biopharmaceuticals Regulatory

HSMN NewsFeed - 28 Jun 2010
Solta Medical Announces Thermage CPT and Fraxel re:store(R) Dual Systems Receive Health Canada Approval
Devices Dermatology Regulatory

HSMN NewsFeed - 11 May 2010
Solta Medical and Alma Lasers Resolve Patent Lawsuits
Devices Litigation

HSMN NewsFeed - 5 May 2010
Syneron Expands Management Team
Devices Personnel

HSMN NewsFeed - 23 Apr 2010
Merz Aesthetics Announces FDA Approval of Asclera(TM) (Polidocanol) Injection, First Sclerosant to Treat Small Varicose Veins in 60 Years
Biopharmaceuticals FDA

HSMN NewsFeed - 15 Apr 2010
Fraxel re:store(R) Dual Laser Proven Effective in Treating Actinic Keratoses, a Common Precancerous Skin Condition
Devices Dermatology

HSMN NewsFeed - 1 Mar 2010
Solta Medical Completes Acquisition of Aesthera Corporation
Devices Mergers & Acquisitions

HSMN NewsFeed - 19 Feb 2010
Merz to Complete Acquisition of BioForm Medical
Devices Mergers & Acquisitions

HSMN NewsFeed - 3 Feb 2010
Medicis Receives Approval for RESTYLANE(R) and PERLANE(R) With Lidocaine
Devices Dermatology FDA

HSMN NewsFeed - 13 Jan 2010
The Foundry Announces Completion of Series A Financing for Twelfth Company
Devices Venture Capital

HSMN NewsFeed - 4 Jan 2010
Merz to Acquire BioForm Medical
Devices Mergers & Acquisitions

HSMN NewsFeed - 4 Jan 2010
Revance Announces Series D Financing
Biopharmaceuticals Drug Delivery Venture Capital

HSMN NewsFeed - 31 Dec 2009
Anika Therapeutics Acquires Fidia Advanced Biopolymers: A Leading Innovator in Hyaluronic Acid Based Tissue Engineered Products
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 18 Nov 2009
Solta Medical Announces New Fraxel re:store(R) Dual Laser System, Receives CE Mark for European Market
Devices Dermatology

HSMN NewsFeed - 13 Oct 2009
Solta Medical, Inc. Appoints Jeffrey Nardoci Vice President of Global Marketing
Devices Personnel

HSMN NewsFeed - 1 Oct 2009
Lumenis(R) Introduces AcuPulse(TM) for Fractional Laser Treatments
Devices Dermatology

HSMN NewsFeed - 28 Sep 2009
Bausch & Lomb Subsidiaries and CROMA will Co-Promote Bromfenac Ophthalmic Solution in Europe
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 15 Jul 2009
Nuvilex Completes First Sale of Last Shot Hangover Remedy(TM)
Biopharmaceuticals

HSMN NewsFeed - 18 May 2009
Cyberonics Names Bryan D. Olin, Ph.D. Vice President, Quality
Devices Neurology Personnel

HSMN NewsFeed - 13 Apr 2009
CoolTouch Inc. Settles Diomed Lawsuit, Files Re-examination Request for Cynosure '873 Patent
Devices Litigation

HSMN NewsFeed - 6 Mar 2009
BioForm Medical to Launch New 1.5cc RADIESSE(r) Volume Advantage Syringe and 0.8cc RADIESSE Moderate Fill Syringe; Announces Successful Results of RADIESSE Dermal Filler With Lidocaine Clinical Study
Biopharmaceuticals Dermatology

HSMN NewsFeed - 5 Mar 2009
Lumenis(R) Introduces LightSheer(R) Duet(TM) for High Speed Permanent Hair Reduction
Devices Dermatology

HSMN NewsFeed - 13 Feb 2009
Haemacure Restructures - Seeks Financing or Sale of the Company
Biopharmaceuticals Devices Surgery Wound Care

HSMN NewsFeed - 10 Feb 2009
Study Demonstrates Restylane(R) Effect Lasted 18 Months in 97% of Patients With One Repeat Injection
Devices

HSMN NewsFeed - 28 Jan 2009
The Foundry Announces New Partners and Completion of Series A Financing for Eleventh Company
Devices Venture Capital Personnel

HSMN NewsFeed - 12 Jan 2009
Thermage, Inc. Announces Name Change to Solta Medical, Inc.
Devices Dermatology

HSMN NewsFeed - 1 Oct 2008
Haemacure Appoints Thomas J. Lynch, J.D., Ph.D. to Board of Directors
Devices Personnel

HSMN NewsFeed - 4 Sep 2008
Microfabrica Secures $22.5 Million Funding to Grow Its Medical Device Business
Devices Venture Capital

HSMN NewsFeed - 15 Aug 2008
IRIDEX Announces FDA Clearance for New Product Family of IRIDEX IQ Laser Systems
Devices FDA

HSMN NewsFeed - 5 Aug 2008
Isolagen, Inc. Reports Positive Top-line Results from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles: Studies Meet All Primary Efficacy Endpoints and are Statistically Significant
Biopharmaceuticals Dermatology

HSMN NewsFeed - 16 Jul 2008
Elemé Medical Announces $18 Million ''Series C'' Financing
Devices Venture Capital

HSMN NewsFeed - 8 Jul 2008
Anika Therapeutics Announces Exclusive U.S. Distribution Agreement for Elevess Injectable Dermal Filler
Devices Dermatology Distribution

HSMN NewsFeed - 30 Jun 2008
FDA Approves EVOLENCE(R), a New Generation Collagen-Based Facial Filler
Devices Dermatology FDA

HSMN NewsFeed - 16 Jun 2008
Medicis to Acquire LipoSonix
Devices Mergers & Acquisitions

HSMN NewsFeed - 10 Jun 2008
CryoLife's BioGlue(R) Surgical Adhesive Receives European Approval for use in Browlift Cosmetic and Reconstructive Plastic Surgery
Devices Regulatory

HSMN NewsFeed - 4 Jun 2008
Allergan Announces Intent to File New Drug Application for Bimatoprost as Novel Treatment to Stimulate Natural Eyelash Growth
Biopharmaceuticals

HSMN NewsFeed - 3 Jun 2008
joimax(R) Revolutionizes Spine Surgery With the Launch of Newest and Fully-Endoscopic Product Innovations to Treat Spinal Canal Stenosis
Devices Orthopaedic

HSMN NewsFeed - 12 May 2008
Revance Announces Series C Expansion
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 6 May 2008
Stiefel Laboratories, Inc. Acquires ABR Invent and ABR Development
Biopharmaceuticals Dermatology Mergers & Acquisitions

HSMN NewsFeed - 1 May 2008
Longport, Inc. Announces Sales Activity from the First Quarter of 2008 and the Publication of an Aesthetics Paper
Devices Wound Care

HSMN NewsFeed - 1 May 2008
Coherent-AMT Changes Company Name to Clarion Medical Technologies Inc.
Devices

HSMN NewsFeed - 28 Apr 2008
North Park Aesthetics Acquires Exclusive Worldwide Rights to Develop and Commercialize Fluridil, a Novel Antiandrogen for Androgenetic Alopecia
Biopharmaceuticals

HSMN NewsFeed - 17 Mar 2008
Organogenesis Names Regenerative Medicine Expert Dr. Damien Bates Vice President, Medical Affairs
Regenerative Medicine Personnel

HSMN NewsFeed - 14 Mar 2008
FDA Gives Go Ahead for Actavis' Irinotecan Hydrochloride Injection
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 27 Feb 2008
JSJ Pharmaceuticals Announces Launch of Aesthetic Division - Vitivia(TM)
Biopharmaceuticals Dermatology

HSMN NewsFeed - 25 Feb 2008
Organogenesis, Inc. Announces Acquisition of NanoMatrix, Inc.
Regenerative Medicine Mergers & Acquisitions

HSMN NewsFeed - 11 Feb 2008
Organogenesis Debuts Educational Campaign for Sufferers of Chronic Leg and Foot Ulcers
Devices Wound Care

HSMN NewsFeed - 23 Jan 2008
Obagi Medical Products Introduces the New ELASTIderm Decolletage System
Biopharmaceuticals Dermatology

HSMN NewsFeed - 17 Jan 2008
Ulthera Receives $22.5 Million in Series B Round
Devices Venture Capital

HSMN NewsFeed - 19 Dec 2007
Javelin Pharmaceuticals Announces Peer-Reviewed Publication of Successful Postoperative Pain Trial with PMI-100/150 (Intranasal Ketamine) in International Journal, ''Acute Pain''
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 12 Dec 2007
Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery
Biopharmaceuticals Dermatology

HSMN NewsFeed - 11 Dec 2007
Organogenesis, Inc. Signs Memorandum of Understanding with Chinese Regenerative Medicine Company
Devices Wound Care Regenerative Medicine

HSMN NewsFeed - 12 Nov 2007
Allergan, Inc. and Covidien Ltd. Enter into Co-Promotion Agreement for LAP-BAND(R) Adjustable Gastric Banding System
Devices

HSMN NewsFeed - 7 Nov 2007
BioForm Announces Pricing of Initial Public Offering
Biopharmaceuticals Dermatology

HSMN NewsFeed - 31 Oct 2007
Allergan, Inc. Receives FDA Approval for COMBIGAN(TM) (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5%
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 17 Oct 2007
Allergan Announces Completion of Esprit Pharma Acquisition
Biopharmaceuticals Urology Mergers & Acquisitions

HSMN NewsFeed - 17 Oct 2007
Theodore A. Boutacoff Appointed President & CEO of IRIDEX
Devices Personnel

HSMN NewsFeed - 9 Oct 2007
ForSight Labs Announces Acquisition of ForSight Newco II by QLT, Inc.
Biopharmaceuticals Ophthalmology Acquisitions

HSMN NewsFeed - 19 Sep 2007
QUANTEL Finalizes the Acquisition of WaveLight Aesthetic GmbH
Devices Dermatology Mergers & Acquisitions

HSMN NewsFeed - 19 Sep 2007
Allergan, Inc. Announces Agreement to Acquire Esprit Pharma, Inc.
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 5 Sep 2007
UltraShape Secures $15.1 Million in New Financing Led by Meritech Capital
Devices Venture Capital

HSMN NewsFeed - 9 Aug 2007
BioForm Licenses U.S. Rights to Leading European Varicose Vein Treatment
Biopharmaceuticals Dermatology Licensing

HSMN NewsFeed - 26 Jul 2007
MAP Pharmaceuticals Appoints General Counsel
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Jul 2007
Bioresorbable Collagen Scaffold Placed inside the Heart Revolutionizes Treatment
Devices Interventional Cardiology Regenerative Medicine

HSMN NewsFeed - 3 Jul 2007
BioForm Strengthens Management Team With Three Leading Industry Executives
Biopharmaceuticals Dermatology Personnel

HSMN NewsFeed - 2 Jul 2007
Mentor Announces Market Launch of NeoForm(TM) Dermis for Breast Reconstruction
Devices

HSMN NewsFeed - 28 Jun 2007
Mentor Enters into Definitive Acquisition Agreement with Shareholders of Perouse Plastie
Devices Mergers & Acquisitions

HSMN NewsFeed - 26 Jun 2007
Allergan Announces FDA Approval of Label Extensions for JUVEDERM(TM) Ultra and JUVEDERM(TM) Ultra Plus
Devices Dermatology FDA

HSMN NewsFeed - 4 Jun 2007
NUCRYST Pharmaceuticals appoints Edward Gaj Jr. Vice President, Corporate Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 May 2007
Medicis Begins Shipping PERLANE to Physicians
Biopharmaceuticals Dermatology

HSMN NewsFeed - 14 May 2007
Syneron Announces Management Change in Support of Company's Long-Term Growth Strategies
Devices Personnel

HSMN NewsFeed - 7 May 2007
Reliant Technologies Receives FDA Clearance for Fraxel re:fine(TM) Laser System
Devices Dermatology FDA

HSMN NewsFeed - 23 Apr 2007
Lifecore Biomedical Announces License Agreement
Biopharmaceuticals Licensing

HSMN NewsFeed - 19 Apr 2007
Sientra Names Three Plastic Surgery Market Veterans to Management Team
Devices Personnel

HSMN NewsFeed - 12 Apr 2007
U.S. Federal Circuit Court Affirms Judgment for Allergan, Inc. and Roche Palo Alto, LLC against Apotex, Inc., Apotex Corp., and Novex Pharma in Ketorolac Patent Infringement Lawsuit
Biopharmaceuticals Ophthalmology Generics Litigation

HSMN NewsFeed - 10 Apr 2007
IRIDEX Announces Settlement of All Litigation with Synergetics
Devices Litigation

HSMN NewsFeed - 13 Mar 2007
Court Rules on All Remaining Motions in IRIDEX Litigation
Devices Litigation

HSMN NewsFeed - 27 Feb 2007
Court Rules Synergetics Infringes IRIDEX Patent
Devices Litigation

HSMN NewsFeed - 22 Feb 2007
Allergan Announces Its Acquisition of EndoArt, a Leading Swiss Developer of Remote-Controlled Medical Devices
Devices Mergers & Acquisitions

HSMN NewsFeed - 1 Feb 2007
UltraShape Appoints Kristine Foss as Vice President Regulatory and Clinical
Devices Dermatology Personnel

HSMN NewsFeed - 17 Jan 2007
IRIDEX Closes Acquisition of Laserscope Aesthetics Business
Devices Mergers & Acquisitions

HSMN NewsFeed - 17 Jan 2007
Allergan, Inc. Announces Nationwide Availability of JUVEDERM(TM) ULTRA and JUVEDERM(TM) ULTRA PLUS Dermal Fillers
Devices

HSMN NewsFeed - 27 Dec 2006
FDA Approves Radiesse(R) Facial Filler for Two New Aesthetic Indications
Devices Dermatology FDA

HSMN NewsFeed - 21 Dec 2006
Allergan Announces FDA Issues Approvable Letter for COMBIGAN(TM) (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5%
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 4 Dec 2006
Allergan Announces New Board Member; Dr. Deborah Dunsire Appointed
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Nov 2006
Artes Medical Names Diane S. Goostree President and Chief Executive Officer
Devices Personnel

HSMN NewsFeed - 17 Nov 2006
Allergan Announces FDA Approval of INAMED(R) Silicone-Filled Breast Implants for Breast Augmentation, Reconstruction and Revision Surgery
Devices FDA

HSMN NewsFeed - 9 Nov 2006
Ivivi Technologies and Allergan Enter into Worldwide Distribution Agreement
Biopharmaceuticals Distribution

HSMN NewsFeed - 30 Oct 2006
CryoLife Announces Agreement With BioForm Medical to Develop and Market BioGlue(R) for Use In Cosmetic and Plastic Surgery
Devices Licensing Distribution

HSMN NewsFeed - 20 Oct 2006
Allergan announces Health Canada grants medical device license to its two silicone-filled breast implant product lines
Devices Regulatory

HSMN NewsFeed - 5 Oct 2006
Allergan Integrates Inamed's Commercial and Research and Development Operations within New Corporate Division, Allergan Medical
Devices Mergers & Acquisitions

HSMN NewsFeed - 26 Sep 2006
Allergan, Inc. Announces Launch of JUVEDERM(TM) ULTRA and JUVEDERM(TM) ULTRA PLUS
Biopharmaceuticals Dermatology

HSMN NewsFeed - 18 Sep 2006
FoxHollow Technologies Increases Depth of Management Team With Two Senior Vice Presidents
Devices Interventional Personnel

HSMN NewsFeed - 20 Jul 2006
Angiotech Selects Independent Sales Rep in Japan for Contour Threads(TM) Product Line
Devices Distribution

HSMN NewsFeed - 17 Jul 2006
WaveLight's ALLEGRETTO WAVE(R) Eye-Q Receives FDA Clearance
Devices Ophthalmology

HSMN NewsFeed - 12 Jul 2006
Kos Submits Supplemental New Drug Application To FDA For New Niaspan(R) CF Range of Products
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 10 Jul 2006
IRIDEX Receives Positive Ruling in Patent Litigation Against Synergetics
Devices Litigation

HSMN NewsFeed - 28 Jun 2006
Angiotech Pharmaceuticals Completes Acquisition of Quill Medical, Inc.
Devices Mergers & Acquisitions

HSMN NewsFeed - 23 Jun 2006
Allergan Announces FDA Approval of LUMIGAN(R) as First-Line Treatment for Elevated Eye Pressure in Open-Angle Glaucoma
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 25 May 2006
Allergan Receives Pan European License for GANFORT(R) (LUMIGAN(R)/Timolol Combination) from European Commission
Biopharmaceuticals Ophthalmology Regulatory

HSMN NewsFeed - 25 May 2006
Angiotech Pharmaceuticals to acquire Quill Medical Inc.
Devices Surgery Mergers & Acquisitions

HSMN NewsFeed - 15 May 2006
Mentor Begins U.S. Phase 1 Study of Its Botulinum Toxin Product for Spasmodic Torticollis/Cervical Dystonia
Biopharmaceuticals

HSMN NewsFeed - 8 May 2006
Medicis Announces FDA Approval of SOLODYN -- minocycline HCl, USP -- Extended Release Tablets
Biopharmaceuticals Dermatology FDA

Return to NewsFeed

Additional items found! 120

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 120 additional stories matching:
aesthetics
(Password required)

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!